Frank J. Secreto

Estrogen Receptor α and β Heterodimers Exert Unique Effects on Estrogen- and Tamoxifen-Dependent Gene Expression in Human U2OS Osteosarcoma Cells

David G. Monroe, Frank J. Secreto, Malayannan Subramaniam et al. · Molecular Endocrinology · 2005 · 131 citations · Full text

Sclerostin, Estrogen Receptor, Cancer Biology +18

Histone Deacetylase 3 Depletion in Osteo/Chondroprogenitor Cells Decreases Bone Density and Increases Marrow Fat

David F. Razidlo, Tiffany J. Whitney, Michelle E. Casper et al. · PLoS ONE · 2010 · 111 citations · Full text

Genetics, Hdac3 Inhibition, Epigenetics +18

Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma

Stephen M. Ansell, Lucy S. Hodge, Frank J. Secreto et al. · Blood Cancer Journal · 2014 · 77 citations · Full text

Myd88 L265p, Myd88 Mutation, Malignant B-cell Growth +22

Natural underlying mt <scp>DNA</scp> heteroplasmy as a potential source of intra‐person hi <scp>PSC</scp> variability

Ester Perales‐Clemente, Alexandra N Cook, Jared M. Evans et al. · The EMBO Journal · 2016 · 75 citations · Full text

Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts

Meghan E. McGee‐Lawrence, Angela L. McCleary‐Wheeler, Frank J. Secreto et al. · Bone · 2011 · 72 citations

Bone Disease, Bone Loss, Biochemistry +11